These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22807549)

  • 41. Clinical evaluation of the BD ProbeTec™ Neisseria gonorrhoeae Qx amplified DNA assay on the BD Viper™ system with XTR™ technology.
    Van Der Pol B; Taylor SN; Lebar W; Davis T; Fuller D; Mena L; Fine P; Gaydos CA; Martin DH; Hook EW
    Sex Transm Dis; 2012 Feb; 39(2):147-53. PubMed ID: 22249304
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative performance of culture using swabs transported in Amies medium and the Aptima Combo 2 nucleic acid amplification test in detection of Neisseria gonorrhoeae from genital and extra-genital sites: a retrospective study.
    Harryman L; Scofield S; Macleod J; Carrington D; Williams OM; Fernandes A; Horner P
    Sex Transm Infect; 2012 Feb; 88(1):27-31. PubMed ID: 22034496
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Abilities of APTIMA, AMPLICOR, and ProbeTec assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in PreservCyt ThinPrep Liquid-based Pap samples.
    Chernesky M; Jang D; Portillo E; Chong S; Smieja M; Luinstra K; Petrich A; Macritchie C; Ewert R; Hayhoe B; Sarabia A; Thompson F
    J Clin Microbiol; 2007 Aug; 45(8):2355-8. PubMed ID: 17537943
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neisseria gonorrhoeae infection in urban Sydney women: prevalence and predictors.
    McDonagh P; Ryder N; McNulty AM; Freedman E
    Sex Health; 2009 Sep; 6(3):241-4. PubMed ID: 19653962
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnosis, management and prevalence estimation of gonorrhoea: influences of Aptima Combo 2 assay with alternative target confirmation.
    Mahto M; Zia S; Ritchie D; Mallinson H
    Int J STD AIDS; 2009 May; 20(5):315-9. PubMed ID: 19386967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analytical specificity and sensitivity of the APTIMA Combo 2 and APTIMA GC assays for detection of commensal Neisseria species and Neisseria gonorrhoeae on the Gen-Probe Panther instrument.
    Golparian D; Tabrizi SN; Unemo M
    Sex Transm Dis; 2013 Feb; 40(2):175-8. PubMed ID: 23324980
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Screening for asymptomatic chlamydia in women: how often would gonorrhoea be missed?
    Mahto M; Lavelle SJ; Mallinson H
    Int J STD AIDS; 2010 Feb; 21(2):149-50. PubMed ID: 20090005
    [No Abstract]   [Full Text] [Related]  

  • 48. Direct real-time PCR-based detection of Neisseria gonorrhoeae 23S rRNA mutations associated with azithromycin resistance.
    Trembizki E; Buckley C; Donovan B; Chen M; Guy R; Kaldor J; Lahra MM; Regan DG; Smith H; Ward J; Whiley DM
    J Antimicrob Chemother; 2015 Dec; 70(12):3244-9. PubMed ID: 26338048
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapid change in the ciprofloxacin resistance pattern among Neisseria gonorrhoeae strains in Nuuk, Greenland: time to reconsider preventive and treatment strategies.
    Rolskov AS; Bjorn-Mortensen K; Mulvad G; Poulsen P; Jensen JS; Pedersen ML
    Int J Circumpolar Health; 2015; 74():26916. PubMed ID: 25947877
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Screening tests for Chlamydia trachomatis or Neisseria gonorrhoeae using the cobas 4800 PCR system do not require a second test to confirm: an audit of patients issued with equivocal results at a sexual health clinic in the Northwest of England, U.K.
    Hopkins MJ; Smith G; Hart IJ; Alloba F
    Sex Transm Infect; 2012 Nov; 88(7):495-7. PubMed ID: 22661631
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular testing (strand displacement assay) for identification of urethral gonorrhoea in men: can it replace culture as the gold standard?
    Wheeler HL; Skinner CJ; Khunda A; Aitken C; Perpanthan D; Staite E
    Int J STD AIDS; 2005 Jun; 16(6):430-2. PubMed ID: 15969778
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of strategies for confirming Neisseria gonorrhoeae nucleic acid amplification tests.
    Alexander S; Coelho da Silva F; Manuel R; Varma R; Ison C
    J Med Microbiol; 2011 Jul; 60(Pt 7):909-912. PubMed ID: 21415207
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is confirmatory testing of Roche cobas 4800 CT/NG test Neisseria gonorrhoeae positive samples required? Comparison of the Roche cobas 4800 CT/NG test with an opa/pap duplex assay for the detection of N gonorrhoeae.
    Perry MD; Jones RN; Corden SA
    Sex Transm Infect; 2014 Jun; 90(4):303-8. PubMed ID: 24653040
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of the APTIMA Combo 2 Assay using self-administered vaginal swabs for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
    Crucitti T; De Deken B; Smet H; Cuylaerts V; Abdellati S; Vuylsteke B
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):385-6. PubMed ID: 23598167
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Auditing the use and assessing the clinical utility of microscopy as a point-of-care test for Neisseria gonorrhoeae in a Sexual Health clinic.
    Mensforth S; Thorley N; Radcliffe K
    Int J STD AIDS; 2018 Feb; 29(2):157-163. PubMed ID: 28705094
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outbreak or illusion: consequences of 'improved' diagnostics for gonorrhoea.
    Bennett A; Jeffery K; O'Neill E; Sherrard J
    Int J STD AIDS; 2017 Jun; 28(7):667-671. PubMed ID: 27405582
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Frequency of Nucleic Acid Amplification Test Positivity Among Men Who Have Sex With Men Returning for a Test-of-Cure Visit 7 to 30 Days After Treatment of Laboratory-Confirmed Neisseria gonorrhoeae Infection at 2 Public Sexual Health Clinics, New York City, 2013 to 2016.
    Okah E; Westheimer EF; Jamison K; Schillinger JA
    Sex Transm Dis; 2018 Mar; 45(3):177-182. PubMed ID: 29420445
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of specimen order on Chlamydia trachomatis and Neisseria gonorrhoeae test performance and adequacy of Papanicolaou smear.
    Ghanem KG; Koumans EH; Johnson RE; Sawyer MK; Papp JR; Unger ER; Black CM; Markowitz LE
    J Pediatr Adolesc Gynecol; 2006 Feb; 19(1):23-30. PubMed ID: 16472725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of six nucleic acid amplification tests used for diagnosis of Neisseria gonorrhoeae in Russia compared with an international strictly validated real-time porA pseudogene polymerase chain reaction.
    Shipitsyna E; Zolotoverkhaya E; Hjelmevoll SO; Maximova A; Savicheva A; Sokolovsky E; Skogen V; Domeika M; Unemo M
    J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1246-53. PubMed ID: 19453773
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gonococcal infection in symptomatic and asymptomatic persons seeking medical clinics in Sofia--a 3-year study 2008-2010.
    Ouzounova-Raykova V; Jordanov D; El-Tibi M; Mitov I
    APMIS; 2011 Dec; 119(12):864-7. PubMed ID: 22085362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.